Home Bulk Chemicals Hexamethylphosphoramide Market Size, Share And Growth Report, 2031

Hexamethylphosphoramide Market

Hexamethylphosphoramide Market Size, Share & Trends Analysis Report By Type (0%-99.5%, >99.5%), By Form (Specialty Solvent, Oxidant) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRCH1238DR
Study Period 2020-2032 CAGR 5.3%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD 4,312.3 million
Forecast Year 2032 Forecast Year Market Size USD 6,863.8 million
Largest Market Europe Fastest Growing Market North America
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global Hexamethylphosphoramide Market size was valued at USD 4,312.3 million in 2023. It is estimated to reach USD 6,863.8 million by 2032, growing at a CAGR of 5.3% during the forecast period (2024–2032).

Hexamethylphosphoramide (HMPA) is an organophosphorus molecule whose chemical formula is (CH3)3N=P(O)CH3. It comprises a phosphorus atom linked to three methyl groups and one nitrogen atom. HMPA is a white liquid that smells like garlic. It is highly polar and miscible with water and many organic solvents. 

The global hexamethylphosphoramide market share is driven by its wide range of applications in the chemical industry, where it acts as a highly polar aprotic solvent and catalyst in various processes, including pharmaceutical and agrochemical production. Its ability to dissolve multiple compounds while serving as a stabilizing catalyst leads to its extensive use. The pharmaceutical and agrochemical industries drive the need for HMPA. However, regulatory constraints and safety concerns may influence market dynamics. As companies seek more efficient solvents and catalysts, the Hexamethylphosphoramide market is expected to increase, aided by increasing research and development in chemical processes.

Market Dynamics

Market Drivers

Growing Pharmaceuticals and Agrochemical Industries

The pharmaceutical and agrochemical industries are significant consumers of HMPA. The substance produces pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and agrochemicals. The expansion of these businesses, fueled by the rising global population and healthcare needs, adds to the need for Hexamethylphosphoramide (HMPA). India has the world's 13th-largest pharmaceutical industry by value and third-largest by volume. In 2023, the Indian pharmaceutical market grew by over 5% yearly, reaching $49.78 billion. Hexamethylphosphoramide makes insecticides, herbicides, and other crop protection agents in agrochemicals. It makes it easier to create pesticide formulations that improve crop output and provide pest and disease protection. According to the World Food Programme (WFP), more than 333 million people will face extreme food insecurity in 2023. This is more than double the figure from 2020. 

Furthermore, According to the US Department of Agriculture, since 2000, the overall area of farmland in the United States has dropped annually. In 2022, the US had 893 million acres of agriculture, a decrease from 915 million acres in 2012. This represents an approximately 23% drop from the 1950 record of 1.16 billion acres. Such factors drive up the demand for agrochemicals. Certain medications and agrochemicals are frequently synthesized using complex chemical processes in which Hexamethylphosphoramide acts as a helpful solvent or catalyst. For example, when creating a particular pesticide or pharmaceutical intermediate, Hexamethylphosphoramide may improve reaction efficiency, contributing to total synthesis. This market expansion suggests a continued demand for specialty chemicals, which will aid the Hexamethylphosphoramide market trend over the forecast period.

Market Restraints

Environmental Regulation

Hexamethylphosphoramide (HMPA) may experience difficulties due to increased scrutiny and legislation about its environmental impact. Environmental concerns may result in increased controls on chemical manufacturing, usage, and disposal, affecting the HMPA industry. Certain compounds, particularly those that pose an environmental risk, may be subject to limits imposed by regulatory agencies in different countries and areas. 

For example, European rules such as REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) and CLP (Classification, Labelling, and Packaging) strive to provide high protection for human health and the environment. According to a European Chemicals Agency (ECHA) report, REACH, which went into effect in 2007, compels enterprises to register compounds they make or import in large quantities. Substances of very high concern (SVHC) require authorization, which means their usage is limited unless particular approval is acquired. Such rules can influence market dynamics for compounds such as HMPA.

Under the Clean Air Act, the Environmental Protection Agency (EPA) classifies Hexamethylphosphoramide as a dangerous air pollutant. According to the Comprehensive Environmental Response, Compensation, and Liability Act, the reportable quantity (RQ) for Hexamethylphosphoramide is one pound. The global movement toward more sustainable and environmentally friendly activities affects regulatory decisions. The chemical industry is moving toward greener options, and compounds that represent environmental dangers may have difficulty satisfying changing regulatory criteria.

Market Opportunity

Growing Solar Industry

The fast rise of the solar sector and the growing demand for renewable energy sources present substantial opportunities for Hexamethylphosphoramide. Hexamethylphosphoramide can be used in solar panel manufacturing processes to create certain photovoltaic materials. In manufacturing thin-film solar cells, HMPA can be used as a solvent and a critical component in synthesizing precursor material. It produces thin films that make up the active layers of solar cells. Thin-film solar technologies, such as CIGS and CdTe cells, are known to use solvents like HMPA in their manufacturing processes. According to the IEA, solar investments are predicted to exceed USD 1 billion daily in 2023, totaling USD 380 billion annually. 

As the solar industry tries to improve solar cell efficiency and performance, HMPA has an opportunity to help create breakthrough materials. This covers the development of innovative materials for next-generation solar devices. HMPA can be used to synthesize specific chemicals or as a catalyst in reactions critical to the development of improved solar materials. For example, HMPA's solvating and catalytic capabilities can help synthesize certain organic photovoltaic materials or produce improved solar panel coatings.

The increased demand for hexamethylphosphoramide in the solar industry is due to its prospective applications in solar panel manufacturing, advanced material development, and collaborative research activities. As the solar energy sector grows globally, HMPA's contribution to developing more efficient and sustainable solar technologies is essential in the expanding renewable energy environment.

Regional Analysis

Europe Dominatesthe Global Market

The global hexamethylphosphoramide market analysis is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

Europe is the most significant global Hexamethylphosphoramide market shareholder and is estimated to grow at a CAGR of 5.4% over the forecast period. Europe has the highest share of the global market due to the increasing use of polyvinyl chloride (PVC), which uses Hexamethylphosphoramide to offer outstanding anti-aging qualities in outdoor products with excellent weather resistance. According to the European Council of Vinyl Manufacturers, around 771,000 tons of PVC are recycled yearly, with an annual European consumption of 5 million tons, accounting for 10% of all European plastics. Furthermore, the increasing demand for plastics in various industries drives demand for PVC and Hexamethylphosphoramide. By 2023, the average use rate for European bioplastics was 82%. This indicates that 1.79 million tons of bioplastics were produced, vs 2.18 million tons of production potential.

Additionally, according to the European Plastic Converters, the plastics business contributes significantly to European welfare by generating 308.93 USD billion in revenue annually. The developing solar sector in this region drives the market expansion of hexamethylphosphoramide, which converts visible light and ultraviolet light into energy. In 2023, the EU installed a record 56 GW of solar capacity, representing a 40% increase from 2022. This expansion has doubled the market in just two years. SolarPower Europe is confident about the prospects for the future. The solar organization anticipates a minimum growth of 50 GW by 2023, with a more optimistic scenario predicting up to 68 GW. By 2026, the yearly market growth might range from 85 to 120 GW.

North America is anticipated to exhibit a CAGR of 5.5% over the forecast period. North America's growing renewable energy sector is expected to boost demand for Hexamethylphosphoramide. The ever-increasing renewable energy sector primarily drives North America's hexamethylphosphoramide market. Hexamethylphosphoramide is utilized to produce an efficient perovskite solar mini-module that generates power. The US Energy Information Administration (EIA) anticipated that renewable electricity generation would increase from 22% in 2022 to 23% in 2023 and 26% in 2024. The EIA also forecast that utility-scale solar installations will more than quadruple from 2022 to a record 24 GW, while wind capacity would increase by 8 GW. According to the National Renewable Energy Laboratory (NREL), the United States installed 11.2 GWac of solar PV in the first half of 2023, the most ever deployed in the first half of a year. This represents a 44% increase over the previous year, demonstrating the solar industry's tremendous expansion. 

Furthermore, the expansion of the pharmaceutical sector in this region is predicted to increase demand for Hexamethylphosphoramide due to the increasing usage of PVC in medical devices, which is expected to continue in the coming years.

The Asia-Pacific region, which includes China, India, Japan, South Korea, and others, has tremendous potential for the Hexamethylphosphoramide industry. Asia-Pacific is a central manufacturing hub, with the chemical industry essential in the global supply chain. Solvents and catalysts, such as HMPA, are in great demand across various sectors, including pharmaceuticals, agrochemicals, and electronics. Population expansion, rising healthcare requirements, and agricultural operations have all contributed to the Asia-Pacific region's flourishing pharmaceutical and agrochemical sectors. 

As of January 28, 2024, Asia's population was 4,771,505,281, accounting for 59.22% of the global population. However, Asia and the Pacific are home to two-thirds of the world's hungry people. According to the Food and Agriculture Organization (FAO), 490 million people in Asia and the Pacific lack sufficient dietary energy to lead a healthy lifestyle. HMPA, crucial in various industries, is in high demand for applications ranging from medicine manufacturing to crop protection. Furthermore, rapid economic expansion in China and India promotes industrialization and infrastructural development. This, in turn, increases the need for chemicals and materials, especially solvents such as HMPA.

Report Scope

Report Metric Details
By Type
  1. 0%-99.5%
  2. >99.5%
By Form
  1. Specialty Solvent
  2. Oxidant
Company Profiles BASF SE Masuda Chemical Industries Co Ltd Alfa Chemistry CarboMer Apollo Scientific Ltd AccuStandard Dr Ehrenstorfer GmbH Ningbo Huajia Chemical Co Ltd Jiangxi JixiangPharmchemical Chemical Co Ltd Jinan FuFang Chemical Co Ltd
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global hexamethylphosphoramide market is segmented based on type, form, and region.

The market is further segmented by type into 0%–99.5% and>99.5%.

0%–99.5% accounts for the largest share of the market.


The 0%-99.5% HMPA sector includes items with purity levels ranging from 0% to 99.5%. In this category, the HMPA solution or compound may contain contaminants or have lower amounts of the primary ingredient. The lower purity level may make this segment appropriate for specific industrial applications where a high purity level is not required. Industries that value cost-effectiveness over ultra-high purity standards may find this category helpful for their operations. However, the exact applications within this segment would be determined by the tolerance of contaminants in the provided industrial processes.


The >99.5% HMPA sector includes goods with a high purity level surpassing 99.5%. This sector is distinguished by a low presence of contaminants, making it ideal for companies with strict needs for pure chemicals. High-purity HMPA is frequently sought in applications where even little contaminants can impact final product quality. Pharmaceuticals, electronics, and high-precision manufacturing industries, which require chemical purity, may prefer HMPA with a purity level of more than 99.5%. The chemical's exceptional purity assures that it does not introduce pollutants that could jeopardize the integrity of processes or end products in these sensitive industries.

The market can be bifurcated by form into specialty solvents and oxidants.

Specialty Solvent generates the most revenue in the market.

Specialty Solvent

Specialty Solvent is a Hexamethylphosphoramide (HMPA) used mainly for its solvent qualities in specialized applications. HMPA, which is recognized for its high polarity and solvating powers, becomes a specialty solvent when used in situations where its particular properties are critical. This type of HMPA may have uses in pharmaceutical industries, where precise solvation is required for specific chemical reactions or the synthesis of high-value chemicals. In sectors that need precise and regulated solvation, the specialty solvent form of HMPA may help optimize operations, increase reaction yields, and improve product quality.


While HMPA is best known for its solvent qualities, its use as an oxidant demonstrates its versatility. In this form, HMPA can act as an oxidizing agent in chemical reactions, aiding activities that require oxidation. The oxidant form of HMPA can be used in specific synthesis methods or reactions that benefit from its oxidative properties. Industries such as organic synthesis, which require controlled oxidation, may use HMPA in its oxidant form to produce the desired chemical reactions. The bifurcation into the oxidant portion indicates HMPA's versatile nature, which caters to various uses beyond its traditional use as a solvent.

Market Size By Type

Recent Developments

  • January 2024- BASF raised prices for MDI in ASEAN and South Asia.
  • December 2023- BASF introduced Irgastab® PUR 71, a cutting-edge antioxidant that enhances regulatory compliance and performance of polyols and polyurethane foams.

Top Key Players

BASF SE Masuda Chemical Industries Co Ltd Alfa Chemistry CarboMer Apollo Scientific Ltd AccuStandard Dr Ehrenstorfer GmbH Ningbo Huajia Chemical Co Ltd Jiangxi JixiangPharmchemical Chemical Co Ltd Jinan FuFang Chemical Co Ltd Others

Frequently Asked Questions (FAQs)

How big is the Hexamethylphosphoramide Market?
The global Hexamethylphosphoramide Market size was valued at USD 4,312.3 million in 2023. It is estimated to reach USD 6,863.8 million by 2032, growing at a CAGR of 5.3% during the forecast period (2024–2032).
Europe region has the highest growth rate in the Hexamethylphosphoramide Market.
Growing Pharmaceuticals and Agrochemical Industries are the key drivers for the growth of the Hexamethylphosphoramide Market.
The key players in the global Hexamethylphosphoramide Market include BASF SE ,Masuda Chemical Industries Co Ltd ,Alfa Chemistry ,CarboMer ,Apollo Scientific Ltd ,AccuStandard ,Dr Ehrenstorfer GmbH.

We are featured on :